Assistant Professor, Internal Medicine, University of Utah School of Medicine
Internal Medicine
Dr. Matthew T. Rondina, MD
Matthew T. Rondina works in the field of Internal Medicine. He studied medicine at University of Utah School of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Matthew Rondina is also a published MD. He has 51 paper published. The most recent paper is: Arf6 arbitrates fibrinogen endocytosis. He is registered with Medicare and accepts Medicare payments.
Publications
- The addition of abdomen and pelvis CT to limited cancer screening does not increase diagnosis of cancer in patients with unprovoked venous thromboembolism.
- Antithrombotic Management of Atrial Fibrillation in the Elderly.
- Polymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome.
- Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis.
- Platelet-Monocyte Aggregate Formation and Mortality Risk in Older Patients With Severe Sepsis and Septic Shock.
- Rivaroxaban for the Long-term Treatment of Spontaneous Ovarian Vein Thrombosis Caused by Factor V Leiden Homozygosity.
- Cerebral venous sinus thrombosis in the setting of combined vaginal contraception.
- Current state of anticoagulants to treat deep venous thrombosis.
- Coefficient of Variation of Coarsely Sampled Heart Rate is Associated With Early Vasopressor Independence in Severe Sepsis and Septic Shock.
- Alterations in Platelet Function During Aging: Clinical Correlations with Thromboinflammatory Disease in Older Adults.
- Reply to Schattner.
- Initial fractal exponent of heart rate variability is associated with success of early resuscitation in patients with severe sepsis or septic shock: a prospective coho...
- Platelets as cellular effectors of inflammation in vascular diseases.
- A sticky story for signal transducer and activator of transcription 3 in platelets.
- Methicillin-resistant Staphylococcus aureus - induced thrombo-inflammatory response is reduced with timely antibiotic administration.
- 18F-FDG PET in the Evaluation of Acuity of Deep Vein Thrombosis.
- Bacteria differentially induce degradation of Bcl xL, a survival protein, by human platelets.
- Argatroban Dose Reductions for Suspected Heparin-Induced Thrombocytopenia Complicated by Child-Pugh Class C Liver Disease (November).
- Targeting Phosphodiesterases in Anti-platelet Therapy.
- Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 alpha.
- Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity.
- In Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A(H1N1).
- Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques.
- A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.
- ACP Journal Club. Review: Graduated compression stockings reduce deep venous thrombosis in hospitalized patients.
- Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke.
- Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation.
- Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia.
- Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.
- Contemporary issues in the prevention and management of postthrombotic syndrome.
- Episodic fevers as a novel feature of the carcinoid syndrome.
- Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adreno...
- Azathioprine-induced warfarin resistance.
- The accuracy of activated partial thromboplastin times when drawn through a peripherally inserted central catheter.
- The treatment of venous thromboembolism in special populations.
- Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets.
- Abdominal aortitis due to Streptococcus pneumoniae and Enterobacter aerogenes: a case report and review.
- Early initiation of statin therapy in acute coronary syndromes: a review of the evidence.
- Achieving National Cholesterol Education Program goals in coronary artery disease.
- Sciatic nerve sarcoidosis: utility of magnetic resonance peripheral nerve imaging and treatment with radiation therapy.
- ACP Journal Club. Local INR control had some effect on the benefits of dabigatran over warfarin for major bleeding in atrial fibrillation.
- The effects of drilling force on cortical temperatures and their duration: an in vitro study.
- Prevention of venous thromboembolism in obesity.
- ACP Journal Club. Oral vitamin K did not reduce bleeding in patients with excessive anticoagulation after receiving warfarin.
- Oral vitamin K did not reduce bleeding in patients with excessive anticoagulation after receiving warfarin.
- Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.
- Comparison of computerized tomography and direct visualization in thoracic pedicle screw placement.
- Inter- and intraobserver reliability of computed tomography in assessment of thoracic pedicle screw placement.
- The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.
- Arf6 arbitrates fibrinogen endocytosis.
Schools
University of Utah
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Utah -
University of Utah School of Medicine
Hospital
-
University of Utah Health Care - Hospital and Clinics
Drug Facts
| NPI NUMBER | 1538183991 | |
| NPPES Provider LastName | RONDINA | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 841480001 | |
| NPPES Provider State | UT | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 29.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538183991 |
| Last Name Of The Provider | RONDINA |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
Dr. Michael B. Noyes, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher P. Carlisle, MD |
|
|
Dr. Stacy Johnson, MD |
|
|
Dr. James E. Hawkes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter S. Lenz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott M. Stevens, MD |
|
|
Dr. Cindi Jo Leech, MD |
|
|
Dr. Tyler H. Buckley, MD |
|
|
Kristin K. McElwain, FNP |
|
|
Melissa L. Heiry, MB |
|
|
Dr. Sara E. Walz, MD |